| Nail Diseases and Treatments | Lifetime | 218 | US 85 | 97.98 |
| COVID-19 and healthcare impacts | Lifetime | 761 | US 265 | 92.95 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 376 | US 157 | 96.48 |
| Fungal Infections and Studies | Lifetime | 607 | US 230 | 96.37 |
| Autoimmune Bullous Skin Diseases | Lifetime | 748 | US 221 | 95.24 |
| Infectious Diseases and Mycology | Lifetime | 509 | US 201 | 94.14 |
| Cancer and Skin Lesions | Lifetime | 962 | US 445 | 93.71 |
| Hair Growth and Disorders | Lifetime | 512 | US 182 | 91.15 |
| Soft tissue tumors and treatment | Lifetime | 185 | US 91 | 90.09 |
| Acne and Rosacea Treatments and Effects | Lifetime | 881 | US 329 | 85.70 |
| Social Media in Health Education | Lifetime | 743 | US 391 | 83.96 |
| Body Image and Dysmorphia Studies | Lifetime | 905 | US 360 | 84.25 |
| Dermatological diseases and infestations | Lifetime | 820 | US 318 | 83.44 |
| Chemotherapy-related skin toxicity | Lifetime | 915 | US 401 | 79.74 |
| Dermatological and COVID-19 studies | Lifetime | 665 | US 179 | 78.15 |
| Dupuytren's Contracture and Treatments | Lifetime | 490 | US 174 | 77.80 |
| Nail Diseases and Treatments | 2021-2025 | 3 | US 2 | 99.48 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 7 | US 3 | 98.81 |
| Plant Pathogens and Fungal Diseases | 2021-2025 | 49 | US 6 | 98.88 |
| Fungal Infections and Studies | 2021-2025 | 45 | US 18 | 98.35 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 97 | US 21 | 96.57 |
| Hair Growth and Disorders | 2021-2025 | 46 | US 16 | 95.52 |
| Dermatology and Skin Diseases | 2021-2025 | 267 | US 69 | 96.12 |
| Cancer and Skin Lesions | 2021-2025 | 80 | US 32 | 91.96 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 197 | US 43 | 94.22 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 208 | US 37 | 95.69 |
| Dermatological diseases and infestations | 2021-2025 | 35 | US 10 | 91.25 |
| Infectious Diseases and Mycology | 2021-2025 | 75 | US 17 | 90.99 |
| melanin and skin pigmentation | 2021-2025 | 137 | US 31 | 90.78 |
| Dermatologic Treatments and Research | 2021-2025 | 252 | US 58 | 90.22 |
| Antifungal resistance and susceptibility | 2021-2025 | 521 | US 122 | 90.38 |
| Genetic and rare skin diseases. | 2021-2025 | 61 | US 17 | 81.77 |
| Chemotherapy-related skin toxicity | 2021-2025 | 66 | US 29 | 85.05 |
| Social Media in Health Education | 2021-2025 | 176 | US 85 | 84.48 |
| Genital Health and Disease | 2021-2025 | 388 | US 125 | 83.40 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 217 | US 49 | 82.95 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 480 | US 142 | 83.51 |
| Body Image and Dysmorphia Studies | 2021-2025 | 222 | US 57 | 81.16 |
| Skin Diseases and Diabetes | 2021-2025 | 106 | US 33 | 76.73 |
| Dermatological and COVID-19 studies | 2021-2025 | 198 | US 38 | 75.26 |
| Oral Health Pathology and Treatment | 2021-2025 | 694 | US 73 | 76.15 |
| Melanoma and MAPK Pathways | 2021-2025 | 719 | US 248 | 73.20 |
| Skin and Cellular Biology Research | 2021-2025 | 316 | US 70 | 72.44 |
| Soft tissue tumors and treatment | 2021-2025 | 62 | US 24 | 66.16 |
| Plant and Fungal Interactions Research | 2021-2025 | 804 | US 136 | 63.72 |
| Medicine and Dermatology Studies History | 2021-2025 | 192 | US 100 | 60.78 |
| Dermatological and Skeletal Disorders | 2021-2025 | 554 | US 148 | 53.03 |
| Congenital limb and hand anomalies | 2021-2025 | 197 | US 44 | 47.98 |
| Sympathectomy and Hyperhidrosis Treatments | 2021-2025 | 599 | US 151 | 43.07 |
| Sex and Gender in Healthcare | 2021-2025 | 762 | US 301 | 39.89 |
| Dupuytren's Contracture and Treatments | 2021-2025 | 293 | US 76 | 34.15 |
